Literature DB >> 1641083

Unilateral thalamic haemorrhage in the pre-term and full-term newborn.

L S De Vries1, M Smet, N Goemans, G Wilms, H Devlieger, P Casaer.   

Abstract

One full-term and three premature newborns with a unilateral thalamic haemorrhage are reported. The lesion was diagnosed using cranial ultrasonography and confirmed in three using magnetic resonance imaging. Severe perinatal asphyxia occurred in all infants. The neonatal clinical history, subsequent neuro-developmental outcome and neuroimaging findings are discussed. As the prognosis appears to be much better than for infants with bilateral thalamic densities, it is important that this type of lesion is recognised as a separate entity.

Entities:  

Mesh:

Year:  1992        PMID: 1641083     DOI: 10.1055/s-2008-1071332

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  4 in total

1.  Cranial ultrasound abnormalities in full term infants in a postnatal ward: outcome at 12 and 18 months.

Authors:  L Haataja; E Mercuri; F Cowan; L Dubowitz
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-03       Impact factor: 5.747

2.  Perinatal cortical infarction within middle cerebral artery trunks.

Authors:  P Govaert; E Matthys; A Zecic; F Roelens; A Oostra; B Vanzieleghem
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-01       Impact factor: 5.747

Review 3.  Fifty years of brain imaging in neonatal encephalopathy following perinatal asphyxia.

Authors:  Floris Groenendaal; Linda S de Vries
Journal:  Pediatr Res       Date:  2016-09-27       Impact factor: 3.756

4.  Early cranial ultrasound findings among infants with neonatal encephalopathy in Uganda: an observational study.

Authors:  Cally J Tann; Margaret Nakakeeto; Cornelia Hagmann; Emily L Webb; Natasha Nyombi; Flaviah Namiiro; Kelly Harvey-Jones; Anita Muhumuza; Kathy Burgoine; Alison M Elliott; Jennifer J Kurinczuk; Nicola J Robertson; Frances M Cowan
Journal:  Pediatr Res       Date:  2016-04-11       Impact factor: 3.756

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.